Boston Partners’s Zimmer Biomet ZBH Stock Holding History

Boston Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51.5M	Sell	569,009 -23,227	-4%	-$2.13M	0.05%	255
2025 Q4	$53.2M	Sell	592,236 -30,069	-5%	-$2.85M	0.06%	261
2025 Q3	$61.4M	Sell	622,305 -59,616	-9%	-$5.91M	0.06%	250
2025 Q2	$62.2M	Sell	681,921 -7,956	-1%	-$769K	0.07%	234
2025 Q1	$78M	Sell	689,877 -941,199	-58%	-$101M	0.09%	211
2024 Q4	$172M	Sell	1,631,076 -1,004,496	-38%	-$108M	0.21%	165
2024 Q3	$284M	Sell	2,635,572 -691,343	-21%	-$75.5M	0.34%	108
2024 Q2	$361M	Buy	3,326,915 +11,976	+0.4%	+$1.41M	0.45%	72
2024 Q1	$437M	Buy	3,314,939 +691,191	+26%	+$86.3M	0.52%	64
2023 Q4	$319M	Sell	2,623,748 -71,084	-3%	-$7.93M	0.42%	82
2023 Q3	$302M	Buy	2,694,832 +608,959	+29%	+$77.3M	0.42%	86
2023 Q2	$304M	Sell	2,085,873 -180,000	-8%	-$24.5M	0.41%	86
2023 Q1	$293M	Sell	2,265,873 -369,517	-14%	-$46.4M	0.4%	85
2022 Q4	$336M	Sell	2,635,390 -8,608	-0.3%	-$999K	0.45%	78
2022 Q3	$276M	Sell	2,643,998 -148,395	-5%	-$16.3M	0.4%	86
2022 Q2	$293M	Sell	2,792,393 -427,858	-13%	-$50.8M	0.41%	84
2022 Q1	$412M	Buy	3,220,251 +58,780	+2%	+$7.09M	0.5%	66
2021 Q4	$390M	Buy	3,161,471 +654,009	+26%	+$85.6M	0.47%	67
2021 Q3	$356M	Buy	2,507,462 +254,705	+11%	+$37.5M	0.45%	73
2021 Q2	$352M	Buy	2,252,757 +51,571	+2%	+$8.35M	0.45%	74
2021 Q1	$342M	Buy	2,201,186 +203,135	+10%	+$31.5M	0.46%	68
2020 Q4	$299M	Sell	1,998,051 -1,048,933	-34%	-$148M	0.46%	69
2020 Q3	$403M	Sell	3,046,984 -280,146	-8%	-$36.6M	0.73%	38
2020 Q2	$386M	Sell	3,327,130 -203,574	-6%	-$23.5M	0.71%	42
2020 Q1	$346M	Sell	3,530,704 -791,447	-18%	-$104M	0.69%	43
2019 Q4	$628M	Buy	4,322,151 +342,998	+9%	+$47.3M	0.83%	30
2019 Q3	$530M	Buy	3,979,153 +193	+0%	+$24.9K	0.72%	38
2019 Q2	$455M	Buy	3,978,960 +2,171,847	+120%	+$254M	0.6%	48
2019 Q1	$224M	Buy	1,807,113 +690,616	+62%	+$78.5M	0.3%	98
2018 Q4	$112M	Buy	1,116,497 +475,107	+74%	+$53.4M	0.16%	164
2018 Q3	$81.9M	Buy	641,390 +25,459	+4%	+$3.03M	0.1%	194
2018 Q2	$66.6M	Buy	615,931 +29,268	+5%	+$3.19M	0.08%	219
2018 Q1	$62.1M	Buy	586,663 +13,454	+2%	+$1.56M	0.07%	222
2017 Q4	$67.2M	Sell	573,209 -394,982	-41%	-$44.7M	0.08%	213
2017 Q3	$110M	Sell	968,191 -347,574	-26%	-$40.1M	0.14%	178
2017 Q2	$164M	Buy	1,315,765 +42,051	+3%	+$4.99M	0.21%	139
2017 Q1	$151M	Buy	1,273,714 +123,553	+11%	+$14M	0.19%	149
2016 Q4	$115M	Sell	1,150,161 -1,011,137	-47%	-$108M	0.15%	165
2016 Q3	$273M	Sell	2,161,298 -1,305,557	-38%	-$161M	0.38%	93
2016 Q2	$405M	Buy	3,466,855 +4,668	+0.1%	+$528K	0.59%	50
2016 Q1	$358M	Sell	3,462,187 -611,062	-15%	-$59.1M	0.53%	54
2015 Q4	$406M	Buy	4,073,249 +146,827	+4%	+$14.4M	0.58%	49
2015 Q3	$358M	Sell	3,926,422 -123,631	-3%	-$12.4M	0.55%	49
2015 Q2	$430M	Buy	4,050,053 +767,542	+23%	+$84.9M	0.62%	47
2015 Q1	$375M	Buy	3,282,511 +26,054	+0.8%	+$2.97M	0.56%	53
2014 Q4	$359M	Buy	3,256,457 +168,929	+5%	+$17.8M	0.54%	57
2014 Q3	$301M	Buy	3,087,528 +890,853	+41%	+$87.6M	0.49%	65
2014 Q2	$222M	Buy	2,196,675 +425,229	+24%	+$41.5M	0.37%	82
2014 Q1	$163M	Buy	+1,771,446	New	+$163M	0.3%	101

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners's ZBH Position: Q1 2026 in Review

Boston Partners reduced its Zimmer Biomet (ZBH) stake by 3.9% in Q1 2026, selling an estimated $2.13M and leaving 569,009 shares worth $51.5M. The position accounts for 0.05% of the portfolio, ranked #255.

Boston Partners first reported a position in ZBH in Q1 2014 and has held it in 49 quarters since. The position peaked at $628M in Q4 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Boston Partners held 569,009 shares of Zimmer Biomet worth $51.5M as of Q1 2026.
Boston Partners sold 23,227 Zimmer Biomet shares in Q1 2026, an estimated $2.13M.
Zimmer Biomet made up 0.05% of Boston Partners's portfolio in Q1 2026, its #255 holding.
Boston Partners first reported a position in Zimmer Biomet in Q1 2014 and has held it in 49 quarters since.
Boston Partners's Zimmer Biomet position peaked at $628M in Q4 2019.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.